Here’s the latest on Marty Makary based on public reporting up to May 2026.
FDA leadership tenure: Makary was nominated by President Trump and confirmed as FDA commissioner in early 2025, after a Senate process that examined his pandemic-era positions and regulatory philosophy. He aimed to modernize regulatory processes and introduce AI-assisted review tools at the agency.[1][2][3]
Public positions during the pandemic: Makary rose to prominence as a critic of certain COVID-19 public health measures and as a vocal proponent of faster access to medical treatments. He drew attention for challenging some prevailing public-health strategies and for speaking frequently on media platforms about the pandemic response.[3][5][1]
Post-confirmation scrutiny and shifts: During confirmation hearings and after taking the role, he faced questions about his views on the abortion drug mifepristone and other pandemic-era policies. While some colleagues acknowledged his surgical expertise and health-policy background, there was ongoing examination of how his past positions would influence FDA decisions and regulatory practices.[4][3]
Departure from FDA: Reports in May 2026 indicated he resigned amid internal and political pressures, with coverage noting ongoing speculation about the Trump administration’s plans for the agency. The resignation would mark a significant turn after his confirmed tenure.[2]
Key takeaways:
Illustration: If you’d like, I can summarize the timeline with a short chart or pull direct quotes from key statements to illustrate how his public positions matched or diverged from FDA policy debates.
Citations:
Dr. Marty Makary rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV.
www.washingtontimes.comShould Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
kffhealthnews.orgPresident-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.
www.cbsnews.comPanelists at a covid conference last fall were asked to voice their regrets — policies they had supported during the pandemic but had come to see as misguided. Covid contact tracing, one said. Closing schools, another said. Vaccine mandates, a third said.
www.news-medical.netDr. Marty Makary rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV.
www.washingtontimes.com